Future with Nintedanib
•
Combination with Immunotherapy
: strong
preclinical evidence
•
Combination with EGFR-TKI
•
Combinations with CT to improve tolerability
:
–
Nab-paclitaxel
–
Docetaxel weekly
•
Investigation of Potential Biomarkers
:
LUME-
BioNIS Study
